VALANTINE HANNAH sold 35.1% of their position (5K shares) of BRIDGEBIO PHARMA, INC. on the open market
Open‑market sale worth $341.5K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+3.99K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+2.81K
Price / share
$41.73
Trade value
$117.18K
% of position
Common Stock
Shares
−2.81K
Price / share
$68.00
Trade value
$190.94K
% of position
Common Stock
Shares
−2.20K
Price / share
$68.57
Trade value
$150.58K
% of position
Net shares
+1.79K
Net value
-$224.35K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/22/2026 | A · Award | +3.99K | — | — | 53.4% | 7.46K | 11.46K |
| Common Stock Direct | 6/22/2026 | M · Option Exercise | +2.81K | $41.73 | $117.18K | 24.5% | 11.46K | 14.26K |
| Common Stock Direct | 6/22/2026 | S · Sale | −2.81K | $68.00 | $190.94K | 19.7% | 14.26K | 11.46K |
| Common Stock Direct | 6/23/2026 | S · Sale | −2.20K | $68.57 | $150.58K | 19.2% | 11.46K | 9.26K |
| Total | +1.79K | -$224.35K | ||||||
Stock Option (Right to Buy)
Common Stock
5.28K shares
Shares
+5.28K
Strike price
68.92
Held after
5.28K
Exercisable
—
Stock Option (Right to Buy)
Common Stock
2.81K shares
Shares
−2.81K
Strike price
41.73
Held after
5.62K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock5.28K shares | 6/22/2026 | A · Award | +5.28K | 68.92 | — | 5.28K |
| Stock Option (Right to Buy) Direct | Common Stock2.81K shares | 6/22/2026 | M · Option Exercise | −2.81K | 41.73 | — | 5.62K |
Common Stock
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 398.00 | Indirect |
| Total | 398.00 | 398.00 indirect |